Evidence map›Paper›PMID 40177102›Full record

ArticleRoyal Society open science2025

Costs and constraints of cellular immune activity during development in an arboreal primate.

Nicole Thompson González, Lucia Freedberg, James Higham, Erin Vogel, Marina Cords

Abstract read
In one paragraph

Article in Royal Society open science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Minimal Evidence of Inflammaging in Naturalistic Chimpanzee Populations.American journal of biological anthropology · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicole Thompson GonzálezIntegrative Anthropological Sciences, University of California Santa Barbara, Santa Barbara, CA, USA.ORCID https://orcid.org/0000-0002-3195-1277
Lucia FreedbergIntegrative Anthropological Sciences, University of California Santa Barbara, Santa Barbara, CA, USA.
James HighamDepartment of Anthropology, New York University, New York, NY, USA.ORCID https://orcid.org/0000-0002-1133-2030
Erin VogelDepartment of Anthropology, Rutgers University, New Brunswick, NJ, USA.ORCID https://orcid.org/0000-0001-6304-5423
Marina CordsDepartment of Ecology, Evolution, and Environmental Biology, Columbia University, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evolutionary life history theory predicts that, during development, investment in immunity must be balanced with the demands of growth. How, and at what time scales, this balance is negotiated is unclear. In this study, we examined the potential energetic costs and limitations to cellular immune activity during development, its trade-offs with growth, related sickness behaviour and the role of hypothalamic-pituitary-adrenal (HPA) axis activity in these relationships. We combined biomarker and socio-environmental data on wild juvenile blue monkeys collected over eight months. Rather than detract from energy balance (C-peptide) and growth of lean body mass (creatinine by specific gravity residuals), cellular immune activity (neopterin) increased with energy balance and lean body mass at monthly time scales, suggesting an energetic constraint on cellular immunity. At shorter time scales, higher neopterin diminished subsequent growth. Energetic constraints on immune activity were weakly regulated by HPA activity during low energy states. Our results suggest that cellular immune activity is both costly and limited by physical condition in wild developing primates.

Indexed as

conservationecoimmunologyenergeticsenergy balanceimmune ontogenylife history

Identifiers

PMID40177102
PMCPMC11961265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.